(Q45195812)

10 December 2017

Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects (English)

1 reference

10 December 2017

1 reference

1 reference

Ritschel WA

1

1 reference

10 December 2017

Parab PV

2

1 reference

10 December 2017

Denson DD

3

1 reference

10 December 2017

Coyle DE

4

1 reference

10 December 2017

Gregg RV

5

1 reference

10 December 2017

1 September 1987

1 reference

The Journal of Clinical Pharmacology

10 December 2017

1 reference

10 December 2017

27

1 reference

10 December 2017

9

1 reference

10 December 2017

647-653

1 reference

Anaesthesia time/dose curves IX: the use of hydromorphone in surgical anaesthesia and postoperative pain relief in comparison to morphine

10 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03082.X

Urinary excretion of hydromorphone and metabolites in humans, rats, dogs, guinea pigs, and rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03082.X

Simultaneous determination of hydromorphone, hydrocodone and their 6alpha- and 6beta-hydroxy metabolites in urine using selected ion recording with methane chemical ionization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03082.X

Pharmacokinetics and Bioavailability of Hydromorphone Following Intravenous and Oral Administration to Human Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03082.X

Therapeutic Drug Monitoring in Saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03082.X

Radioimmunoassay of hydromorphone and hydrocodone in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03082.X

10.1002/J.1552-4604.1987.TB03082.X

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference